Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2014-09-30

FDA Approved: HYZAAR — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) from Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyzaar (losartan/hydrochlorothiazide)

Snippet

SUPPL AP for HYZAAR (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE)